DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a generative artificial intelligence healthcare company focused on developing and commercializing CERVAI™, a proprietary brain health AI platform. A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool. The Brain Age Estimation tool includes a novel electroencephalogram headset and machine-learning model. It integrates proprietary software into unified and standardized data recording protocols. The Brain Health Assessment tool generates clinician-observed measures and a brain health score. These combined allow users to be proactive in achieving their brain health goals.